U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 119

1.
Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
Sophie Lehnerer, Meret Herdick, Regina Stegherr, Lea Gerischer, Frauke Stascheit, Maike Stein, Philipp Mergenthaler, Sarah Hoffmann, Andreas Meisel
J Neurol. 2024; 271(5): 2824–2839. Published online 2024 Feb 29. doi: 10.1007/s00415-024-12206-6
PMCID:
PMC11055781
ArticlePDF–900K
2.
Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome
Naoya Ishibashi, Toshiharu Tabata, Ryo Nonomura, Yutaka Oshima, Takanobu Sasaki, Hideki Mitomo, Takafumi Sugawara, Motoyasu Sagawa
Respir Med Case Rep. 2024; 47: 101974. Published online 2023 Dec 23. doi: 10.1016/j.rmcr.2023.101974
PMCID:
PMC10874974
ArticlePDF–2.7M
3.
Acute onset of Lambert Eaton myasthenic syndrome in prostate adenocarcinoma: a case report
Nicu Cătălin Drăghici, Elena Olariu, Tudor Dimitrie Lupescu, Fior Dafin Mureşanu
Med Pharm Rep. 2024 Jan; 97(1): 95–98. Published online 2024 Jan 29. doi: 10.15386/mpr-2541
PMCID:
PMC10852129
ArticlePDF–1.6M
4.
Unusual paraneoplastic syndromes in pancreatic cancer: a case report of Lambert-Eaton myasthenic syndrome (LEMS) associated with intraductal papillary mucinous cancer of the pancreas
Athanasios Zamparas, Torsten Herzog, Sarah Förster, Ines Siglienti, Waldemar Uhl, Johanna Strotmann, Philipp Höhn
AME Case Rep. 2023; 7: 35. Published online 2023 Aug 14. doi: 10.21037/acr-22-108
PMCID:
PMC10628391
ArticlePDF–812K
5.
A rare case of concomitant Lambert–Eaton myasthenic syndrome and syndrome of inappropriate antidiuretic hormone secretion in a patient with small cell lung carcinoma
Yasuharu Oda, Hironobu Tsubouchi, Nobuyuki Ishii, Aya Kitamura, Eiji Moriyama, Eriko Mitsutome, Katsuya Sakai, Kazutaka Shiomi, Shigehisa Yanagi, Taiga Miyazaki
Respir Med Case Rep. 2023; 46: 101930. Published online 2023 Oct 19. doi: 10.1016/j.rmcr.2023.101930
PMCID:
PMC10618749
ArticlePDF–1.7M
6.
Spontaneous regression of small cell lung cancer associated with Lambert-Eaton Myasthenic Syndrome: Case report
Michimi Otani, Miki Nishimori, Hitomi Iwasa, Mamiko Iwamura, Takayasu Izumi, Kosuke Nakaji, Noriko Nitta, Kana Miyatake, Rika Yoshimatsu, Tomoaki Yamanishi, Tomohiro Matsumoto, Yasushi Osaki, Noriko Wada, Makoto Toi, Marino Yamamoto, Yu Nakatani, Tetsuya Kubota, Takuji Yamagami
Radiol Case Rep. 2023 Nov; 18(11): 4036–4041. Published online 2023 Sep 2. doi: 10.1016/j.radcr.2023.08.059
PMCID:
PMC10480669
ArticlePDF–1.9M
7.
Dilated fixed pupils and respiratory failure: a rare clinical course of Lambert-Eaton myasthenic syndrome
Michelle FM ten Brinck, Inge WH Verheijen, Jaron van de Wardt, Gert W van Dijk, Frouke AP Nijhuis, Aad Verrips
BMJ Neurol Open. 2023; 5(2): e000426. Published online 2023 Aug 18. doi: 10.1136/bmjno-2023-000426
PMCID:
PMC10441110
ArticlePDF–268K
8.
Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer
Yuki Takigawa, Hiromi Watanabe, Yoshio Omote, Sunao Kurihara, Tomoyoshi Inoue, Miho Fujiwara, Sho Mitsumune, Kiriko Onishi, Kenichiro Kudo, Akiko Sato, Ken Sato, Keiichi Fujiwara, Takuo Shibayama
Intern Med. 2023 Apr 1; 62(7): 1055–1058. Published online 2022 Aug 30. doi: 10.2169/internalmedicine.0072-22
PMCID:
PMC10125817
ArticlePDF–1001K
9.
Lambert‐Eaton myasthenic syndrome with primary thymic marginal zone B‐cell lymphoma: A case report
Toshihiko Soma, Akira Matsumoto, Tsuyoshi Shoji, Hiromichi Katakura
Respirol Case Rep. 2023 May; 11(5): e01149. Published online 2023 Apr 18. doi: 10.1002/rcr2.1149
PMCID:
PMC10111402
ArticlePDF–870K
10.
Durvalumab for Extensive-Stage of Small-Cell Lung Cancer With Lambert-Eaton Myasthenic Syndrome
Hirotomo Machiyama, Seigo Minami
J Med Cases. 2023 Feb; 14(2): 71–75. Published online 2023 Feb 25. doi: 10.14740/jmc4043
PMCID:
PMC9990708
ArticlePDF–1.6M
11.
Atezolizumab-Induced Lambert-Eaton Myasthenic Syndrome in a Patient With Small-Cell Lung Cancer
Masami Yamazoe, Taku Hatakeyama, Kento Furukawa, Koji Kato, Kazuhiro Horiuchi
Cureus. 2023 Jan; 15(1): e33557. Published online 2023 Jan 9. doi: 10.7759/cureus.33557
PMCID:
PMC9908354
ArticlePDF–409K
12.
Exploring the role of immune checkpoint inhibitors in the etiology of myasthenia gravis and Lambert-Eaton myasthenic syndrome: A systematic review
Carly Seligman, Yu-Mei Chang, Jie Luo, Oliver A. Garden
Front Neurol. 2022; 13: 1004810. Published online 2023 Jan 9. doi: 10.3389/fneur.2022.1004810
PMCID:
PMC9868566
ArticlePDF–1.2M
13.
Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
Robert M Pascuzzi, Cynthia L Bodkin
Neuropsychiatr Dis Treat. 2022; 18: 3001–3022. Published online 2022 Dec 22. doi: 10.2147/NDT.S296714
PMCID:
PMC9792103
ArticlePDF–579K
14.
Combined treatment with radiotherapy, chemotherapy and avelumab results in regression of metastatic Merkel cell carcinoma and improvement of associated Lambert-Eaton myasthenic syndrome: A case report
Caroline Green, Martin Isaksson Mettävainio, Christina Kjellman, Torbjörn Ramqvist, Tina Dalianis, Pernilla Israelsson, David Lindquist
Oncol Lett. 2022 Nov; 24(5): 393. Published online 2022 Sep 21. doi: 10.3892/ol.2022.13513
PMCID:
PMC9533363
ArticlePDF–922K
15.
Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
Hiroaki Yoshikawa, Yumi Adachi, Yosikazu Nakamura, Nagato Kuriyama, Hiroyuki Murai, Yoshiko Nomura, Yasunari Sakai, Kazuo Iwasa, Yutaka Furukawa, Satoshi Kuwabara, Makoto Matsui
BMJ Neurol Open. 2022; 4(2): e000291. Published online 2022 Sep 5. doi: 10.1136/bmjno-2022-000291
PMCID:
PMC9445827
ArticlePDF–602K
16.
The European Lambert–Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment
Andreas Meisel, Jörn P. Sieb, Gwendal Le Masson, Ville Postila, Sabrina Sacconi
Neurol Ther. 2022 Sep; 11(3): 1071–1083. Published online 2022 May 5. doi: 10.1007/s40120-022-00354-8
PMCID:
PMC9338181
ArticlePDF–575K
17.
Long-Standing Lambert–Eaton Myasthenic Syndrome Caused by Undetectable Small-Cell Lung Cancer: Why We Should Follow-Up LEMS
Bo Young Hong, Ho Jung An, Seong Hoon Lim
Diagnostics (Basel) 2022 Jul; 12(7): 1542. Published online 2022 Jun 24. doi: 10.3390/diagnostics12071542
PMCID:
PMC9318534
ArticlePDF–372K
18.
Lambert-Eaton Myasthenic Syndrome in Lung Cancer
Yongbin Wang, Chuanguo Xu, Yu Wang, Feifei Feng, Hui Wang, Ying Zhang, Xiaojuan Lin, Bin Xu
Contrast Media Mol Imaging. 2022; 2022: 3912376. Published online 2022 Jul 5. doi: 10.1155/2022/3912376
PMCID:
PMC9277170
ArticlePDF–383K
19.
Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer
Eiji Kunii, Sota Owaki, Kazuki Yamada, Misuzu Yoshihara, Yusuke Yamaba, Osamu Takakuwa, Takanari Toyoda, Kenji Akita
Intern Med. 2022 Jun 1; 61(11): 1739–1742. Published online 2021 Oct 26. doi: 10.2169/internalmedicine.8387-21
PMCID:
PMC9259317
ArticlePDF–1.3M
20.
Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States
Scott P. Ginebaugh, Yomna Badawi, Tyler B. Tarr, Stephen D. Meriney
Biomolecules. 2022 Jun; 12(6): 740. Published online 2022 May 24. doi: 10.3390/biom12060740
PMCID:
PMC9221282
ArticlePDF–1.6M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center